TY - JOUR
T1 - Split-protein systems
T2 - Beyond binary protein-protein interactions
AU - Shekhawat, Sujan S.
AU - Ghosh, Indraneel
N1 - Funding Information:
We thank past and present members of the Ghosh laboratory particularly Ben Jester and Jenny Furman for their thoughtful contributions. I.G. acknowledges support from the NSF ( CHE-0548264 ) and NIH ( CA141974 and CA143661 ).
PY - 2011/12
Y1 - 2011/12
N2 - It has been estimated that 650,000 protein-protein interactions exist in the human interactome (Stumpf et al., 2008 [1]), a subset of all possible macromolecular partnerships that dictate life. Thus there is a continued need for the development of sensitive and user-friendly methods for cataloguing biomacromolecules in complex environments and for detecting their interactions, modifications, and cellular location. Such methods also allow for establishing differences in the interactome between a normal and diseased cellular state and for quantifying the outcome of therapeutic intervention. A promising approach for deconvoluting the role of macromolecular partnerships is split-protein reassembly, also called protein fragment complementation. This approach relies on the appropriate fragmentation of protein reporters, such as the green fluorescent protein or firefly luciferase, which when attached to possible interacting partners can reassemble and regain function, thereby confirming the partnership. Split-protein methods have been effectively utilized for detecting protein-protein interactions in cell-free systems, Escherichia coli, yeast, mammalian cells, plants, and live animals. Herein, we present recent advances in engineering split-protein systems that allow for the rapid detection of ternary protein complexes, small molecule inhibitors, as well as a variety of macromolecules including nucleic acids, poly(ADP) ribose, and iron sulfur clusters. We also present advances that combine split-protein systems with chemical inducers of dimerization strategies that allow for regulating the activity of orthogonal split-proteases as well as aid in identifying enzyme inhibitors. Finally, we discuss autoinhibition strategies leading to turn-on sensors as well as future directions in split-protein methodology including possible therapeutic approaches.
AB - It has been estimated that 650,000 protein-protein interactions exist in the human interactome (Stumpf et al., 2008 [1]), a subset of all possible macromolecular partnerships that dictate life. Thus there is a continued need for the development of sensitive and user-friendly methods for cataloguing biomacromolecules in complex environments and for detecting their interactions, modifications, and cellular location. Such methods also allow for establishing differences in the interactome between a normal and diseased cellular state and for quantifying the outcome of therapeutic intervention. A promising approach for deconvoluting the role of macromolecular partnerships is split-protein reassembly, also called protein fragment complementation. This approach relies on the appropriate fragmentation of protein reporters, such as the green fluorescent protein or firefly luciferase, which when attached to possible interacting partners can reassemble and regain function, thereby confirming the partnership. Split-protein methods have been effectively utilized for detecting protein-protein interactions in cell-free systems, Escherichia coli, yeast, mammalian cells, plants, and live animals. Herein, we present recent advances in engineering split-protein systems that allow for the rapid detection of ternary protein complexes, small molecule inhibitors, as well as a variety of macromolecules including nucleic acids, poly(ADP) ribose, and iron sulfur clusters. We also present advances that combine split-protein systems with chemical inducers of dimerization strategies that allow for regulating the activity of orthogonal split-proteases as well as aid in identifying enzyme inhibitors. Finally, we discuss autoinhibition strategies leading to turn-on sensors as well as future directions in split-protein methodology including possible therapeutic approaches.
UR - http://www.scopus.com/inward/record.url?scp=83055186516&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=83055186516&partnerID=8YFLogxK
U2 - 10.1016/j.cbpa.2011.10.014
DO - 10.1016/j.cbpa.2011.10.014
M3 - Review article
C2 - 22070901
AN - SCOPUS:83055186516
SN - 1367-5931
VL - 15
SP - 789
EP - 797
JO - Current Opinion in Chemical Biology
JF - Current Opinion in Chemical Biology
IS - 6
ER -